Pancreatic Cancer Research

ResearcherMeiwa HospitalNo recent work listed

Takashi Sonoda

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5112312144. Sources: OpenAlex.

Their work

Papers
4 (first author 3, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
5
Papers, trials and grants by year

2015: 1 paper · 2016: none · 2017: none · 2018: 1 paper · 2019: 1 paper · 2020: none · 2021: none · 2022: 1 paper

Papers 4

  1. First-Line Gemcitabine, Nab-Paclitaxel, and Oxaliplatin Chemotherapy With Itraconazole in Patients With Metastatic Pancreatic Cancer: A Single Institution Expe… Last author DOI 10.21873/anticanres.16118↗
  2. A combination of platelet-to-lymphocyte ratio and carbohydrate antigen 19-9 predict early recurrence after resection of pancreatic ductal adenocarcinoma. First author DOI 10.21037/atm.2019.08.35↗
  3. The preoperative modified Glasgow prognostic score for the prediction of survival after pancreatic cancer resection following non-surgical treatment of an init… First author DOI 10.5114/wo.2018.81344↗
  4. Combination Chemotherapy with Itraconazole for Treating Metastatic Pancreatic Cancer in the Second-line or Additional Setting. First author PMID 26124377↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Shinichi Ikuta · 4 shared papers, 2015–2022 · strength 0.48
  2. Naoki Yamanaka · 3 shared papers, 2015–2019 · strength 0.30
  3. Hiroshi Tsubamoto · 2 shared papers, 2015–2022 · strength 0.23
  4. Miyuki Sawasaki · 1 shared paper, 2022 · strength 0.17
  5. Takayoshi Nakajima · 1 shared paper, 2018 · strength 0.11

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.